Drug Type Molecular glue |
Synonyms BCL6 LDD, BMS 986458 |
Target |
Mechanism BCL6 inhibitors(B-cell lymphoma 6 protein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Hodgkin Lymphoma | Phase 1 | US | 29 Dec 2023 | |
Non-Hodgkin Lymphoma | Phase 1 | FR | 29 Dec 2023 | |
Non-Hodgkin Lymphoma | Phase 1 | NL | 29 Dec 2023 | |
Non-Hodgkin Lymphoma | Phase 1 | ES | 29 Dec 2023 | |
Non-Hodgkin Lymphoma | Phase 1 | CH | 29 Dec 2023 |